Bruker Corporation (BRKR) Financials
BRKR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 6.1 billion | 3.6 billion |
| Dec. 31, 2025 | 6.2 billion | 3.7 billion |
| Sept. 30, 2025 | 6.4 billion | 3.9 billion |
| June 30, 2025 | 6.3 billion | 4.5 billion |
BRKR Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 47.0 million | ? |
| Dec. 31, 2025 | 207.2 million | ? |
| Sept. 30, 2025 | -54.1 million | 6.0 million |
| June 30, 2025 | -148.8 million | ? |
BRKR Net Income
| Date | Net Income |
|---|---|
| March 31, 2026 | 15.7 million |
| Dec. 31, 2025 | 29.2 million |
| Sept. 30, 2025 | -58.5 million |
| June 30, 2025 | 4.2 million |
BRKR Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 133.4 million | 1.7 billion | - |
| Dec. 31, 2025 | 298.8 million | 1.7 billion | 296.6 million |
| Sept. 30, 2025 | 293.1 million | 2.0 billion | - |
| June 30, 2025 | 92.0 million | 2.4 billion | - |
BRKR Shares Outstanding
BRKR Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 24.2 million | 101.3 million | 242.1 million | - |
| Dec. 31, 2025 | 22.6 million | 99.6 million | 247.2 million | - |
| Sept. 30, 2025 | 20.9 million | 98.3 million | 242.5 million | - |
| June 30, 2025 | 21.3 million | 100.2 million | 231.4 million | - |
BRKR Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 823.4 million | 434.1 million |
| Dec. 31, 2025 | 977.2 million | 528.0 million |
| Sept. 30, 2025 | 860.5 million | 481.1 million |
| June 30, 2025 | 797.4 million | 439.5 million |
BRKR Revenue by Segment
BRKR
Price: $60.45
Dividend Yield: 0.32%
Forward Dividend Yield: 0.33%
Payout Ratio: 8.37%
Dividend Per Share: 0.20 USD
Earnings Per Share: -0.24 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 459000
Ebitda: 109.4 millionMarket Capitalization: 9.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 11
DGR3: 3.70%
DGR5: 4.72%